DEF: Solitron Devices Schedules 2026 Annual Stockholder Meeting

Sentiment:

Proxy Statement


Solitron Devices, Inc. announces its 2025 Annual Meeting of Stockholders for April 24, 2026, to vote on director election, auditor ratification, and executive compensation.

Worse than expectedNet income decreased significantly from $5,801,000 in fiscal year 2024 to $815,000 in fiscal year 2025, representing an 86% decline.Total Shareholder Return (TSR) decreased from $187.00 in fiscal year 2024 to $159.00 in fiscal year 2025, indicating a decline in shareholder value over the most recent year.

Summary

  • The 2025 Annual Meeting of Stockholders will be held on Friday, April 24, 2026, at 10:00 a.m. Eastern Time, at 901 Sansburys Way, West Palm Beach, Florida.
  • Stockholders will vote on the election of one Class III director, Charles M. Gillman, to serve for a term until the 2028 Annual Meeting of Stockholders.
  • The ratification of Whitley Penn LLP as the Company's independent certified public accountants for the fiscal year ending February 28, 2026, will be put to a vote.
  • A non-binding advisory vote on the compensation of the named executive officers of the Company (Say on Pay) will also take place.
  • As of the record date, February 27, 2026, there were 2,147,703 shares of common stock outstanding, each entitled to one vote.
  • Net income significantly decreased from $5,801,000 in fiscal year 2024 to $815,000 in fiscal year 2025.
  • Total Shareholder Return (TSR) for a $100 investment grew to $159.00 by February 28, 2025, from $100.80 in 2023, but decreased from $187.00 in 2024.
  • Auditor fees for Whitley Penn were $161,969 in fiscal 2025 and $170,000 in fiscal 2024, with additional audit-related fees of $151,700 in fiscal 2024 for the Micro Engineering, Inc. acquisition.
  • The Company purchased $106,000 of die from ES Components in fiscal 2025, a related party where director Dwight P. Aubrey is a minority owner.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with mixed sentiment. While corporate governance structures appear sound and TSR has grown over three years, the substantial year-over-year decline in net income and past regulatory issues for two directors are significant concerns.

Positives

  • Four out of five directors (Messrs. Aubrey, Chiste, Gillman, and Pointer) meet the criteria for independence specified in the Nasdaq Stock Market Marketplace Rules.
  • All directors attended at least 75% of all Board meetings and committee meetings on which each served during fiscal year 2025.
  • The Company has adopted a Code of Ethics for senior officers and charters for its Audit, Compensation, and Nominating Committees, which are published on its website.
  • The Board has separated the roles of Chairman and Chief Executive Officer, believing it provides an appropriate leadership structure for the Company at this time.
  • The executive compensation program was approved on an advisory basis by approximately 79% of the votes cast at the 2024 annual meeting of stockholders.
  • Total Shareholder Return (TSR) for a $100 investment increased to $159.00 by February 28, 2025, from $100.80 in 2023, indicating long-term shareholder value growth.

Negatives

  • Net income significantly decreased from $5,801,000 in fiscal year 2024 to $815,000 in fiscal year 2025, representing an 86% decline.
  • Two directors, David W. Pointer and Charles M. Gillman, have past legal/disciplinary histories with regulatory bodies (State of Washington DFI and SEC, respectively).
  • No stock awards were granted to named executive officers or non-employee directors in fiscal years 2024 or 2025.
  • The Compensation Committee did not meet during fiscal year 2025, and the Nominating Committee did not meet but took one action by unanimous written consent.
  • Total Shareholder Return (TSR) decreased from $187.00 in fiscal year 2024 to $159.00 in fiscal year 2025, indicating a decline in shareholder value over the most recent year.

Risks

  • The Audit Committee is primarily responsible for overseeing the risk management function, specifically with respect to management's assessment of risk exposures (including risks related to liquidity, credit, operations, and regulatory compliance).
  • In uncontested director elections, an incumbent director must submit an irrevocable resignation contingent on not receiving a majority of votes cast, which the Board may or may not accept.
  • Broker non-votes will have no effect on the election of directors or the Say on Pay proposal, but abstentions will have the same effect as a vote against the auditor ratification and Say on Pay proposals.
  • The Compensation Committee determined that risks arising from the Company's compensation policies and practices for its employees are not reasonably likely to have a material adverse effect on the Company.

Future Outlook

The Company will hold its 2025 Annual Meeting of Stockholders on April 24, 2026, where stockholders will elect a Class III director to serve until the 2028 Annual Meeting and ratify the selection of Whitley Penn LLP as auditors for the fiscal year ending February 28, 2026. The next advisory vote on the frequency of the Say on Pay proposal is scheduled for the 2027 annual meeting. Stockholder proposals for the 2026 Annual Meeting must be received by November 10, 2026, to be included in the proxy statement.

Management Comments

  • The Board decided to separate the positions of Chairman and Chief Executive Officer because the Board believes that doing so provides the appropriate leadership structure for the Company at this time.
  • The Board of Directors believes that our executive compensation programs are designed to secure and retain the services of high quality executives and to provide compensation to our executives that are commensurate and aligned with our performance and advances both the short and long-term interests of our company and our stockholders.
  • The Board of Directors believes that our compensation program for our named executive officers for the fiscal year ended February 28, 2025 was appropriately based upon our performance and the individual performance and level of responsibility of the executive officers.

Industry Context

StockSavvy.ai notes that the semiconductor components industry, in which Solitron Devices operates, is highly specialized and often serves niche markets such as defense or aerospace. The company's focus on corporate governance and executive compensation, as detailed in this proxy statement, is standard practice for publicly traded companies in this sector, aiming to ensure investor confidence and align management incentives. The significant drop in net income, despite an increase in TSR over a three-year period, suggests potential volatility or specific operational challenges that warrant closer examination within the broader industry context.

Comparison to Industry Standards

  • The separation of Chairman and CEO roles aligns with best practices in corporate governance, often seen in larger, more mature companies like Intel or Texas Instruments, to enhance independent oversight, though Solitron is a micro-cap.
  • The Say on Pay approval rate of 79% in 2024 is generally considered acceptable, though below the higher approval rates often seen in companies with consistently strong financial performance or more robust shareholder engagement on compensation, such as Analog Devices or NXP Semiconductors.
  • The decline in net income from $5.8 million to $0.8 million in a single year is a significant underperformance compared to many industry peers who might experience cyclical downturns but typically not such a sharp drop without a major external event or internal restructuring. For example, while the broader semiconductor market can be volatile, companies like ON Semiconductor or Microchip Technology often manage to maintain more stable profitability or provide clear explanations for declines.
  • The past regulatory issues of two directors, while disclosed, could be viewed as a governance concern compared to the stricter standards often upheld by larger, more established industry players.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerTim EriksenCarolyn CampbellSeptember 16, 2024Appointment of new CFO, Mr. Eriksen remained CEO.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director Compensation AdjustmentAnnual cash compensation for Chairman David Pointer increased to $40,000, Audit Committee Chairman John Chiste to $30,000, Compensation Committee Chairman Dwight Aubrey to $28,000, and Nominating Committee Chairman Charles Gillman to $24,000.March 1, 2024Aims to better compensate non-employee directors for their roles and responsibilities.
Board Leadership StructureThe Board has separated the roles of Chairman of the Board (David W. Pointer) and Chief Executive Officer (Tim Eriksen).July 22, 2016 (Chairman appointment)Intended to allow the CEO to focus on business management and strategic initiatives while the Chairman leads Board responsibilities, enhancing independent oversight.
Code of Ethics AdoptionAdopted a Code of Ethics for senior officers, including the principal executive officer, principal financial officer, and controller.Not specified, but published on websiteEnhances ethical conduct and compliance with Sarbanes-Oxley Act requirements.
Committee ChartersAdopted and published charters for the Audit Committee, Compensation Committee, and Nominating Committee on the Company's website.Not specified, but published on websiteProvides clear guidelines for committee responsibilities and operations, promoting transparency and accountability.
Insider Trading PolicyImplemented a policy prohibiting officers, directors, and employees with access to material nonpublic information from conducting transactions involving Company securities while in possession of such information.Not specified, filed as Exhibit 19.1 to 10-KAims to prevent insider trading and maintain market integrity.
Anti-Hedging PoliciesProhibits all officers, directors, and employees from engaging in hedging, pledging, or shorting transactions involving Company securities.Not specifiedAligns management and director interests with long-term shareholder value by preventing offsetting of market value decreases.

Legal Proceedings

  • David W. Pointer, Chairman of the Board, and V.I. Capital Management, LLC were subject to a consent order from the State of Washington Department of Financial Institutions, Securities Division, dated March 12, 2018. Allegations included failure to disclose conflicts of interest, pledging investment fund assets as collateral for CompuMed, Inc. without disclosure, and failure to timely distribute audited financial statements. Conditions included a cease and desist order, a $10,000 fine, $2,500 in costs, and Mr. Pointer's agreement not to be a principal, officer, or owner of an investment adviser or broker-dealer for 10 years.
  • Charles M. Gillman, a director, was subject to an SEC administrative order, dated February 14, 2017. Allegations included violations of Section 13(d) of the Exchange Act (failing to disclose stockholder group members) and Section 16(a) of the Exchange Act (failing to timely file beneficial ownership statements). Mr. Gillman agreed to cease and desist from such violations and paid a civil penalty of $30,000.

Related Party Transactions

  • The Company purchased $106,000 of die from ES Components in fiscal year ended February 28, 2025. Director Dwight P. Aubrey is a minority owner, and an immediate family member of Mr. Aubrey is the majority owner of ES Components.
  • The Company purchased $79,000 of die from ES Components in fiscal year ended February 29, 2024.
  • Sales from the Company to ES Components were $0 for both fiscal years 2025 and 2024.

Stakeholder Impact

  • Shareholders: Will vote on key governance matters including director election, auditor ratification, and executive compensation. The significant drop in net income could impact future share price and dividends (none issued recently). Past regulatory issues of directors could be a concern for some investors.
  • Employees/Officers/Directors: Executive compensation details are provided, with salary increases for the CEO and COO. The 2019 Stock Incentive Plan provides a framework for equity awards, though none were granted in the last two fiscal years. Insider trading and anti-hedging policies are in place.
  • Customers: The company's business involves semiconductor components, implying customer relationships, but no direct impact is detailed in this filing.
  • Auditors: Whitley Penn LLP's selection is up for ratification, and their fees for audit and tax services are disclosed.

Next Steps

  • Stockholders to vote on director election, auditor ratification, and Say on Pay at the Annual Meeting on April 24, 2026.
  • The Board of Directors will act on any incumbent director's resignation if they fail to receive a majority vote in an uncontested election within 90 days following certification of election results.
  • The Audit Committee will re-evaluate its selection of Whitley Penn LLP if stockholders do not ratify their selection.
  • The next advisory vote on the frequency of the Say on Pay proposal will be held at the 2027 annual meeting of stockholders.
  • Stockholder proposals for the 2026 Annual Meeting must be received by November 10, 2026, to be included in the proxy statement.
  • Stockholders intending to solicit proxies for director nominees must provide notice by February 24, 2026 (or later if the meeting date changes significantly).

Key Dates

DateDescription
1979Mr. Aubrey founded Compatible Components, Inc.
1981Mr. Aubrey became President of ES Components LLC.
1983Mr. Chiste served as Senior Manager with Ernst & Young LLP until 1992.
1992Mr. Chiste served as CFO of Computer Integration Corp. until 1997.
1997Mr. Chiste served as CFO of Bluegreen Corporation until 2005.
1998Mr. Matson was a Vice President at Advanced Digital Information Corporation until 2003.
2003Mr. Matson was General Manager and COO for Benchmark Electronics' Division in Redmond, Washington until 2005.
2005Mr. Eriksen founded Eriksen Capital Management LLC (ECM).
2005Mr. Chiste served as CFO of the Falcone Group since this year.
January 2006Mr. Matson was Vice President of Global Operations and Engineering for Rockford Corporation until December 2010.
2006Mr. Eriksen founded Cedar Creek Partners LLC (CCP).
January 1, 2008Mr. Pointer founded VI Capital Management, LLC (VICM).
February 2008Mr. Chiste was a director and Chairman of the Audit Committee of Forward Industries, Inc. through January 2015.
December 2010Mr. Matson served as COO and VP of Operations at YSI until March 2012.
March 2012Mr. Matson provided consulting services through Avlet, Denali Advanced Integration and Tuxedo Technologies until May 2016.
2013Mr. Gillman founded IDWR Multi-Family Office.
January 2014Mr. Pointer was a member of the Board of Directors of CompuMed, Inc. through June 2023.
January 12, 2015Mr. Aubrey and Mr. Chiste were appointed directors.
August 4, 2015Mr. Eriksen and Mr. Pointer were elected directors.
May 2016Mr. Matson served as a consultant to the Company through July 2016.
July 22, 2016Mr. Gillman was appointed a director.
July 22, 2016Mr. Eriksen was appointed Chief Executive Officer and Chief Financial Officer.
July 22, 2016Mr. Pointer was named Chairman of the Board.
February 14, 2017SEC administrative order against Charles M. Gillman.
2017Mr. Aubrey restarted Compatible Components LLC as a consulting company.
March 12, 2018Consent order from State of Washington DFI, Securities Division against V.I. Capital Management, LLC and David W. Pointer.
March 2018Mr. Pointer served as CEO and Board Member of Novation Companies Inc. through January 2022.
April 2018Mr. Eriksen served as a director and member of the Audit Committee of Novation Companies Inc. through August 2021.
June 28, 2019The 2019 Stock Incentive Plan was created.
October 22, 2019Mr. Eriksen was elected a director of TSR Inc.
August 31, 2021Mr. Eriksen was elected to the board of PharmChem, Inc.
February 28, 2022Baseline date for $100 investment for Total Shareholder Return calculation.
April 2022Ms. Campbell served as CFO of Medmasa, LLC through September 2024.
February 28, 2023End of fiscal year for which Net Income was $826,000 and TSR was $100.80.
August 30, 2023Whitley Penn became independent certified public accountants.
September 1, 2023Micro Engineering, Inc. acquisition completed.
September 1, 2023CCP became the largest shareholder of PharmChem, and Mr. Eriksen was appointed Chairman of PharmChem's board.
November 2023VI Capital Fund, LP liquidated.
January 26, 2024Date of Schedule 13G/A filing by Granite State Capital Management, LLC.
February 19, 2024Company modified director compensation and increased executive base salaries, effective March 1, 2024.
February 29, 2024End of fiscal year for which Net Income was $5,801,000 and TSR was $187.00.
June 2024TSR Inc. acquired by Vienna Parent, ending Mr. Eriksen's directorship.
September 16, 2024Carolyn Campbell was appointed Chief Financial Officer; Tim Eriksen ceased being CFO.
December 2024Mr. Eriksen was appointed to the board of Paragon Technologies Inc.
February 28, 2025End of fiscal year for which Net Income was $815,000 and TSR was $159.00.
August 27, 2025Date of Form 4 filing by Olesen Value Fund L.P.
February 24, 2026Deadline for stockholders to provide notice for director nominees under universal proxy rules for the 2026 Annual Meeting (if meeting date is not changed by more than 30 days).
February 27, 2026Record date for stockholders entitled to vote at the 2025 Annual Meeting.
February 28, 2026Fiscal year end for which Whitley Penn LLP is selected as independent certified public accountants.
March 6, 2026Date of the Notice of 2025 Annual Meeting of Stockholders.
March 10, 2026Approximate date of mailing Notice of Internet Availability of Proxy Materials to stockholders.
April 23, 2026Deadline for Internet/Mobile proxy votes (11:59 p.m. Eastern Time).
April 24, 2026Date of the 2025 Annual Meeting of Stockholders.
November 10, 2026Deadline for stockholder proposals for the 2026 Annual Meeting to be included in the proxy statement.
2027Next advisory vote on the frequency of the Say on Pay vote.
2028Term expiration for the Class III director to be elected at the 2025 Annual Meeting.

Recommendation

hold

This filing is a routine proxy statement for an annual meeting, which typically does not contain highly price-sensitive information. While the significant drop in net income from the previous fiscal year is a concern, this financial data would have been disclosed in the earlier 10-K filing. The governance issues (past regulatory actions for directors) are also historical and disclosed. The company maintains a stable board and compensation structure. Given the mixed financial performance (declining net income but positive TSR over three years) and the routine nature of the proposals, a "hold" recommendation is appropriate for existing investors awaiting further operational and financial updates. New investors might exercise caution due to the net income decline and governance history.

Keywords

Solitron Devices, SEC filing, DEF 14A, proxy statement, annual meeting, corporate governance, director election, executive compensation, auditor ratification, financial performance, net income, total shareholder return, related party transactions, semiconductor components, micro-cap stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.